US medication safety agency approves biannual preventive HIV shot

The US has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday.

It’s the first step in an anticipated global rollout that could protect millions – although it’s unclear how many in the U.S. and abroad will get access to the powerful new option.

While a vaccine to prevent HIV still is needed, some experts say the shot — a drug called lenacapavir — could be the next best thing. It…